Skip to main content
. 2021 Oct 15;22(20):11150. doi: 10.3390/ijms222011150
BCa Bladder cancer;
T2DM Type 2 diabetes mellitus;
PLEKHS1 Pleckstrin homology domain containing S1;
IGF Insulin-like growth factor;
NMIBC Non-muscle invasive bladder cancer;
MIBC Muscle invasive bladder cancer;
IGF-I Insulin-like growth factor I;
IGF-II Insulin-like growth factor II;
IGF1R Insulin-like growth factor 1 receptor;
IGF2R Insulin-like growth factor 2 receptor;
IGFBP Insulin-like growth factor binding protein;
IR Insulin receptor;
ALS Acid labile sub-unit;
RR Risk Ratio;
CI Confidence Interval;
OR Odds Ratio;
P p-value;
Measure of heterogeneity;
HR Hazard Ratio;
BMI Body mass index;